MedPath

Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates

Not Applicable
Terminated
Conditions
Psychosis
Aggression
Registration Number
NCT00203775
Lead Sponsor
University of Connecticut
Brief Summary

This study examines the efficacy of haldol versus risperdal in the treatment of aggression in psychotic prison inmates. It is hypothsized that risperdal will be more effective in decreasing aggression than haldol.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

age 18 or over, psychotic disorder diagnosed on SCID, inmate at correctional facility for at least 2 weeks -

Exclusion Criteria

active withdrawal from substances of abuse, non-psychotic individuals, pregnant women, people unable to give informed consent, patients on mood stabilizers

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of connecticut health center

🇺🇸

Farmington, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath